Two Popular Altcoins Announce Partnership for New Blockchain Network: Key Developments for Coin Name (Symbol)

ARB

ARB/USDT

$0.1124
-4.01%
24h Volume

$35,745,663.72

24h H/L

$0.1178 / $0.1122

Change: $0.005600 (4.99%)

Long/Short
56.1%
Long: 56.1%Short: 43.9%
Funding Rate

+0.0055%

Longs pay

Data provided by COINOTAG DATALive data
ARB
ARB
Daily

$0.1123

-1.06%

Volume (24h): -

Resistance Levels
Resistance 3$0.1252
Resistance 2$0.1187
Resistance 1$0.1134
Price$0.1123
Support 1$0.1103
Support 2$0.1048
Support 3$0.0994
Pivot (PP):$0.112733
Trend:Downtrend
RSI (14):36.8
(04:22 AM UTC)
2 min read

Contents

988 views
0 comments
  • Injective (INJ), a Layer 1 blockchain, has partnered with Arbitrum (ARB) for a critical development.
  • Injective is rolling up its sleeves to launch a Layer-3 (L3) blockchain on the Arbitrum network.
  • Eric Chen, co-founder of Injective Labs, stated that the product to be offered will provide significant benefits to the ecosystem by enabling the transfer of liquidity and assets across multiple blockchains.

Injective partners with Arbitrum to launch a Layer-3 blockchain, aiming to enable cross-chain asset and liquidity transfer, bridging the gap between Ethereum, Cosmos, and other widely adopted L1s.

Injective Partners with Arbitrum for Layer-3 Blockchain Launch

Injective, a Layer 1 blockchain, has announced a partnership with Arbitrum for a significant development. The team at Injective has revealed plans to launch a Layer-3 (L3) blockchain on the Arbitrum network, aiming to create a fast and low-cost network.

Using Arbitrum’s Technology for Cross-Chain Asset and Liquidity Transfer

The “inEVM”, which will connect Ethereum, Cosmos, and Solana networks and assist in cross-chain asset and liquidity transfer, will also allow the creation of customizable blockchains with Arbitrum’s technology. This integration goes beyond just creating blockchain networks or infrastructure. It applies the fundamental principle of interoperability by bridging the gap between Ethereum, Cosmos, and other widely adopted L1s, truly unifying cross-chain assets and liquidity across ecosystems.

Significant Benefits to the Ecosystem

Eric Chen, the co-founder of Injective Labs, commented on the matter, stating that the product to be offered will provide significant benefits to the ecosystem. By enabling the transfer of liquidity and assets across multiple blockchains, it will enhance the interoperability and efficiency of transactions across these networks.

Conclusion

The partnership between Injective and Arbitrum signifies a significant step towards enhancing cross-chain interoperability. While no specific date has been shared for when the L3 project will be implemented, the development is eagerly awaited by the crypto community.

Add COINOTAG as a Preferred Source

Add COINOTAG to your preferred sources in Google News and Search to see our coverage first.

Add on Google
JM

James Mitchell

COINOTAG author

View all posts

Comments

Comments